Publications for Mariana Babayeva

Touro College of Pharmacy (New York)
  • Babayeva, M., Assefa, H., Basu, P., Chumki, S., & Loewy, Z. (2016). Marijuana compounds: A nonconventional approach to Parkinson’s disease therapy. Parkinson's Disease, 2016 [Article 1279042]. doi:10.1155/2016/1279042

  • Vysotski, S., Winzelberg, R., & Babayeva, M. (2016). Overcoming cancer multidrug resistance through inhibition of microparticles. GSTF International Journal of Advances in Medical Research, 1(4). This material can be found here.

  • Jiang, J. K., McCoy, J. G., Shen, M., LeClair, C. A., Huang, W., Negri, A., . . . Babayeva, M. (2014). A novel class of ion displacement ligands as antagonists of the αIIbβ3 receptor that limit conformational reorganization of the receptor. Bioorganic & Medicinal Chemistry Letters, 24(4), 1148-1153. doi:10.1016/j.bmcl.2013.12.122

  • Mullokandov, E., Ahn, J., Szalkiewicz, A., & Babayeva, M. (2014). Protein binding drug-drug interaction between warfarin and tizoxanide in human plasma. Austin Journal of Pharmacolology and Therapeutics, 2(7) [Article id1038]. This material can be found here.

  • White, M. P., Babayeva, M., Taft, D. R., & Maniar, M. (2013). Determination of intestinal permeability of rigosertib (ON 01910.Na, Estybon): Correlation with systemic exposure. Journal of Pharmacy and Pharmacology, 65(7), 960-969.  doi:10.1111/jphp.12057

  • Babayeva, M., Cox, S., White, M. P., & Taft, D. R. (2011). Renal excretion of apricitabine in rats: Ex vivo and in vivo studies. European Journal of Drug Metabolism and Pharmacokinetics, 36(3), 141-150. doi:10.1007/s13318-011-0038-9

  • Nakatani-Freshwater, T., Babayeva, M., Dontabhaktuni, A., & Taft, D. (2006). Effects of trimethoprim on the clearance of apricitabine, a deoxycytidine analog reverse transcriptase inhibitor, and lamivudine in the isolated perfused rat kidney. Journal of Pharmacology and Experimental Therapeutics 319(2), 941-947. doi:10.1124/jpet.106.108522